Literature DB >> 30905192

Gut Microbiota Composition and Blood Pressure.

Shan Sun1, Anju Lulla2, Michael Sioda1, Kathryn Winglee1, Michael C Wu3, David R Jacobs4, James M Shikany5, Donald M Lloyd-Jones6, Lenore J Launer7, Anthony A Fodor1, Katie A Meyer2,8.   

Abstract

Animal models support a role for the gut microbiota in the development of hypertension. There has been a lack of epidemiological cohort studies to confirm these findings in human populations. We examined cross-sectional associations between measures of gut microbial diversity and taxonomic composition and blood pressure (BP) in 529 participants of the biracial (black and white) CARDIA study (Coronary Artery Risk Development in Young Adults). We sequenced V3-V4 regions of the 16S ribosomal RNA marker gene using DNA extracted from stool samples collected at CARDIA's Year 30 follow-up examination (2015-2016; aged 48-60 years). We quantified associations between BP (hypertension [defined as systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg or antihypertension medication use] and systolic BP) and within and between-person diversity measures. We conducted genera-specific multivariable-adjusted regression analysis, accounting for multiple comparisons using the false discovery rate. Hypertension and systolic BP were inversely associated with measures of α-diversity, including richness and the Shannon Diversity Index, and were distinguished with respect to principal coordinates based on a similarity matrix of genera abundance. Several specific genera were significantly associated with hypertension and systolic BP, though results were attenuated with adjustment for body mass index. Our findings support associations between within-person and between-person gut microbial community diversity and taxonomic composition and BP in a diverse population-based cohort of middle-aged adults. Future study is needed to define functional pathways that underlie observed associations and identify specific microbial targets for intervention.

Entities:  

Keywords:  blood pressure; epidemiology; gastrointestinal microbiome; hypertension; population

Mesh:

Substances:

Year:  2019        PMID: 30905192      PMCID: PMC6458072          DOI: 10.1161/HYPERTENSIONAHA.118.12109

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  45 in total

1.  Longitudinal trends in diet and effects of sex, race, and education on dietary quality score change: the Coronary Artery Risk Development in Young Adults study.

Authors:  Femke P C Sijtsma; Katie A Meyer; Lyn M Steffen; James M Shikany; Linda Van Horn; Lisa Harnack; Daan Kromhout; David R Jacobs
Journal:  Am J Clin Nutr       Date:  2012-02-01       Impact factor: 7.045

2.  Validity and Reliability of Short Physical Activity History: Cardia and the Minnesota Heart Health Program.

Authors:  David R Jacobs; Lorraine P Hahn; William L Haskell; Phyllis Pirie; Stephen Sidney
Journal:  J Cardiopulm Rehabil       Date:  1989-11       Impact factor: 2.081

3.  A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice.

Authors:  Hubert Plovier; Amandine Everard; Céline Druart; Clara Depommier; Matthias Van Hul; Lucie Geurts; Julien Chilloux; Noora Ottman; Thibaut Duparc; Laeticia Lichtenstein; Antonis Myridakis; Nathalie M Delzenne; Judith Klievink; Arnab Bhattacharjee; Kees C H van der Ark; Steven Aalvink; Laurent O Martinez; Marc-Emmanuel Dumas; Dominique Maiter; Audrey Loumaye; Michel P Hermans; Jean-Paul Thissen; Clara Belzer; Willem M de Vos; Patrice D Cani
Journal:  Nat Med       Date:  2016-11-28       Impact factor: 53.440

4.  Role of the Gut Microbiome in Obstructive Sleep Apnea-Induced Hypertension.

Authors:  David J Durgan; Bhanu P Ganesh; Julia L Cope; Nadim J Ajami; Sharon C Phillips; Joseph F Petrosino; Emily B Hollister; Robert M Bryan
Journal:  Hypertension       Date:  2015-12-28       Impact factor: 10.190

5.  Alterations in the gut microbiota can elicit hypertension in rats.

Authors:  Sareema Adnan; James W Nelson; Nadim J Ajami; Venugopal R Venna; Joseph F Petrosino; Robert M Bryan; David J Durgan
Journal:  Physiol Genomics       Date:  2016-12-23       Impact factor: 3.107

6.  Metabolomics and incident hypertension among blacks: the atherosclerosis risk in communities study.

Authors:  Yan Zheng; Bing Yu; Danny Alexander; Thomas H Mosley; Gerardo Heiss; Jennifer A Nettleton; Eric Boerwinkle
Journal:  Hypertension       Date:  2013-06-17       Impact factor: 10.190

7.  The Gut Microbiome Contributes to a Substantial Proportion of the Variation in Blood Lipids.

Authors:  Jingyuan Fu; Marc Jan Bonder; María Carmen Cenit; Ettje F Tigchelaar; Astrid Maatman; Jackie A M Dekens; Eelke Brandsma; Joanna Marczynska; Floris Imhann; Rinse K Weersma; Lude Franke; Tiffany W Poon; Ramnik J Xavier; Dirk Gevers; Marten H Hofker; Cisca Wijmenga; Alexandra Zhernakova
Journal:  Circ Res       Date:  2015-09-10       Impact factor: 17.367

8.  Revealing the bacterial butyrate synthesis pathways by analyzing (meta)genomic data.

Authors:  Marius Vital; Adina Chuang Howe; James M Tiedje
Journal:  MBio       Date:  2014-04-22       Impact factor: 7.867

9.  Short-Chain Fatty Acid Propionate Protects From Hypertensive Cardiovascular Damage.

Authors:  Hendrik Bartolomaeus; András Balogh; Mina Yakoub; Susanne Homann; Lajos Markó; Sascha Höges; Dmitry Tsvetkov; Alexander Krannich; Sebastian Wundersitz; Ellen G Avery; Nadine Haase; Kristin Kräker; Lydia Hering; Martina Maase; Kristina Kusche-Vihrog; Maria Grandoch; Jens Fielitz; Stefan Kempa; Maik Gollasch; Zhaxybay Zhumadilov; Samat Kozhakhmetov; Almagul Kushugulova; Kai-Uwe Eckardt; Ralf Dechend; Lars Christian Rump; Sofia K Forslund; Dominik N Müller; Johannes Stegbauer; Nicola Wilck
Journal:  Circulation       Date:  2019-03-12       Impact factor: 29.690

10.  Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity.

Authors:  Alexandra Zhernakova; Alexander Kurilshikov; Marc Jan Bonder; Ettje F Tigchelaar; Melanie Schirmer; Tommi Vatanen; Zlatan Mujagic; Arnau Vich Vila; Gwen Falony; Sara Vieira-Silva; Jun Wang; Floris Imhann; Eelke Brandsma; Soesma A Jankipersadsing; Marie Joossens; Maria Carmen Cenit; Patrick Deelen; Morris A Swertz; Rinse K Weersma; Edith J M Feskens; Mihai G Netea; Dirk Gevers; Daisy Jonkers; Lude Franke; Yurii S Aulchenko; Curtis Huttenhower; Jeroen Raes; Marten H Hofker; Ramnik J Xavier; Cisca Wijmenga; Jingyuan Fu
Journal:  Science       Date:  2016-04-28       Impact factor: 47.728

View more
  56 in total

1.  Fecal microbiota signatures of insulin resistance, inflammation, and metabolic syndrome in youth with obesity: a pilot study.

Authors:  Federica Del Chierico; Melania Manco; Simone Gardini; Valerio Guarrasi; Alessandra Russo; Marzia Bianchi; Valentina Tortosa; Andrea Quagliariello; Blegina Shashaj; Danilo Fintini; Lorenza Putignani
Journal:  Acta Diabetol       Date:  2021-03-22       Impact factor: 4.280

Review 2.  Gut Microbial Metabolites and Blood Pressure Regulation: Focus on SCFAs and TMAO.

Authors:  Brian G Poll; Muhammad Umar Cheema; Jennifer L Pluznick
Journal:  Physiology (Bethesda)       Date:  2020-07-01

Review 3.  Gut Microbiome over a Lifetime and the Association with Hypertension.

Authors:  Yuichiro Yano; Teemu J Niiranen
Journal:  Curr Hypertens Rep       Date:  2021-03-08       Impact factor: 5.369

4.  Machine Learning Strategy for Gut Microbiome-Based Diagnostic Screening of Cardiovascular Disease.

Authors:  Sachin Aryal; Ahmad Alimadadi; Ishan Manandhar; Bina Joe; Xi Cheng
Journal:  Hypertension       Date:  2020-09-10       Impact factor: 10.190

5.  Diurnal Timing Dependent Alterations in Gut Microbial Composition Are Synchronously Linked to Salt-Sensitive Hypertension and Renal Damage.

Authors:  Saroj Chakraborty; Juthika Mandal; Xi Cheng; Sarah Galla; Anay Hindupur; Piu Saha; Beng San Yeoh; Blair Mell; Ji-Youn Yeo; Matam Vijay-Kumar; Tao Yang; Bina Joe
Journal:  Hypertension       Date:  2020-05-26       Impact factor: 10.190

Review 6.  Blood pressure management in an ecosystem context.

Authors:  Yuichiro Yano
Journal:  Hypertens Res       Date:  2020-05-21       Impact factor: 3.872

Review 7.  Genomic Determinants of Hypertension With a Focus on Metabolomics and the Gut Microbiome.

Authors:  Panayiotis Louca; Cristina Menni; Sandosh Padmanabhan
Journal:  Am J Hypertens       Date:  2020-05-21       Impact factor: 2.689

8.  Intestinal Microbiota in the SARS-CoV-2 Infection: What Is Known?

Authors:  Patrícia Brito Rodrigues; Arilson Bernardo Dos Santos Pereira Gomes; Lívia Moreira Genaro; Lívia Bitencourt Pascoal; Ana Paula Duarte de Souza; Raquel Franco Leal; Marco Aurélio Ramirez Vinolo
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  Metabolites and Hypertension: Insights into Hypertension as a Metabolic Disorder: 2019 Harriet Dustan Award.

Authors:  Saroj Chakraborty; Juthika Mandal; Tao Yang; Xi Cheng; Ji-Youn Yeo; Cameron G McCarthy; Camilla F Wenceslau; Lauren G Koch; Jennifer W Hill; Matam Vijay-Kumar; Bina Joe
Journal:  Hypertension       Date:  2020-04-27       Impact factor: 10.190

10.  Changes to the gut microbiota induced by losartan contributes to its antihypertensive effects.

Authors:  Iñaki Robles-Vera; Marta Toral; Néstor de la Visitación; Manuel Sánchez; Manuel Gómez-Guzmán; Raquel Muñoz; Francesca Algieri; Teresa Vezza; Rosario Jiménez; Julio Gálvez; Miguel Romero; Juan Miguel Redondo; Juan Duarte
Journal:  Br J Pharmacol       Date:  2020-02-03       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.